US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ENGENE HOLDINGS INC

6.37

-0.5900-8.48%

Post-market: 6.370.00000.00%18:59 EDT

Volume:162.39K

Turnover:1.06M

Market Cap:426.69M

PE:-2.83

High:7.06

Open:6.92

Low:6.22

Close:6.96

52wk High:12.25

52wk Low:2.65

Shares:66.98M

Float Shares:37.33M

Volume Ratio:1.14

T/O Rate:0.43%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.2529

EPS(LYR):-2.2947

ROE:-46.07%

ROA:-25.63%

PB:1.52

PE(LYR):-2.78

Loading ...

Overview Company News Filings

enGene Holdings (ENGN) Valuation in Focus Following Promising Phase 2 Bladder Cancer Trial Results

Simply Wall St.

Exchange-Traded Funds Lower, Equity Futures Mixed Pre-Bell Thursday Amid Expected Economic Data Gaps

MT Newswires Live

EnGene Prices $130 Million Offering of Common Shares, Warrants

MT Newswires Live

BRIEF-Engene Holdings Prices 12,558,823 Common Shares At $8.50 Per Share

enGene Holdings Inc - Pricing of 12,558,823 Common Shares at a Public Offering Price of $8.50 per Share

THOMSON REUTERS

Could a Shift in enGene (ENGN) Trial Endpoints Reveal New Priorities in Its Clinical Strategy?

Simply Wall St.

EnGene Launches Offering of Common Shares

MT Newswires Live

BRIEF-enGene Holdings Files For Offering Of Common Shares, Size Not Disclosed - SEC Filing

enGene Holdings Files for Offering of Common Shares, Size Not Disclosed - SEC Filing

THOMSON REUTERS

enGene Announces Proposed Public Offering Of Common Shares

enGene Holdings Is Maintained at Market Outperform by Citizens

UBS Boosts Price Target on enGene Holdings to $10 From $4, Keeps Neutral Rating

MT Newswires Live

enGene Holdings Inc : UBS Raises Target Price to $10 From $4

THOMSON REUTERS

Dow Gains More Than 300 Points; Energy Vault Holdings Shares Jump

enGene Holdings Up Over 61%, on Pace for Largest Percent Increase Since February 2024 -- Data Talk

enGene Holdings Inc trading resumes

enGene reports detalimogene shows complete response rate of 62% at 6 months

BRIEF-Detalimogene Demonstrates Improved Complete Response Rate Of 62% At 6 Months

enGene Reports 62% Complete Response Rate at 6 Months in Phase 2 Bladder Cancer Trial

Detalimogene Demonstrates Improved Complete Response Rate of 62% at 6 Months

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ENGN/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"ENGN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ENGN\",,,,,undefined,":{"symbol":"ENGN","market":"US","secType":"STK","nameCN":"ENGENE HOLDINGS INC","latestPrice":6.37,"timestamp":1774641600000,"preClose":6.96,"halted":0,"volume":162386,"hourTrading":{"tag":"盘后","latestPrice":6.37,"preClose":6.37,"latestTime":"18:59 EDT","volume":20,"amount":128.28,"timestamp":1774652362416,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.08477011494252872,"floatShares":37332800,"shares":66984661,"eps":-2.2529,"marketStatus":"Market Closed","change":-0.59,"latestTime":"03-27 16:00:00 EDT","open":6.92,"high":7.06,"low":6.22,"amount":1060017.972062,"amplitude":0.12069,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-2.2529,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774857600000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":6.96,"postHourTrading":{"tag":"盘后","latestPrice":6.37,"preClose":6.37,"latestTime":"18:59 EDT","volume":20,"amount":128.28,"timestamp":1774652362416,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.140524},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ENGN\",,,,,undefined,":{"symbol":"ENGN","floatShares":37332800,"roa":"-25.63%","roe":"-46.07%","lyrEps":-2.294663,"volumeRatio":1.140524,"shares":66984661,"dividePrice":0,"high":7.06,"amplitude":0.12069,"preClose":6.96,"low":6.22,"week52Low":2.65,"pbRate":"1.52","week52High":12.25,"institutionHeld":0,"latestPrice":6.37,"eps":-2.2529,"divideRate":0,"volume":162386,"delay":0,"ttmEps":-2.2529,"open":6.92,"prevYearClose":9.03,"prevWeekClose":7.21,"prevMonthClose":10.11,"prevQuarterClose":9.03,"fiveDayClose":7.21,"twentyDayClose":10.11,"sixtyDayClose":8.95},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ENGN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-09","symbol":"ENGN","fiscalQuarterEnding":"2026/01","expectedEps":-0.55,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1773028800000,"reportTimeType":"pre","actualEps":-0.44},{"market":"US","date":"2025-12-22","symbol":"ENGN","fiscalQuarterEnding":"2025/10","expectedEps":-0.55,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1766379600000,"reportTimeType":"post","actualEps":-0.73},{"market":"US","date":"2025-09-11","symbol":"ENGN","fiscalQuarterEnding":"2025/07","expectedEps":-0.49,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1757563200000,"reportTimeType":"post","actualEps":-0.57},{"market":"US","date":"2025-06-12","symbol":"ENGN","fiscalQuarterEnding":"2025/04","expectedEps":-0.5,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1749700800000,"reportTimeType":"pre","actualEps":-0.51},{"market":"US","date":"2025-03-10","symbol":"ENGN","fiscalQuarterEnding":"2025/01","expectedEps":-0.37,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1741579200000,"reportTimeType":"post","actualEps":-0.48}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ENGN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ENGN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.4167,"hold":0.0833,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4167,"analysts":12,"updateTime":1769832000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ENGN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ENGN","date":"2026-03-26","current":-2.827467,"percent":0.500882,"low":-11.074501,"twenty":-6.344748,"median":-3.882418,"eighty":-2.601469,"high":-1.741293,"avg":-4.427318,"sd":1.773767,"marketCap":473615524},"quantilePoints":[{"date":"2023-11-24","current":-7.107113,"twenty":-7.362609,"median":-7.152095,"eighty":-7.017149,"marketCap":183264010},{"date":"2023-12-01","current":-6.8912,"twenty":-7.362609,"median":-7.170087,"eighty":-7.020748,"marketCap":177696496},{"date":"2023-12-08","current":-6.666292,"twenty":-8.564557,"median":-7.174585,"eighty":-6.887602,"marketCap":171897002},{"date":"2023-12-15","current":-6.641012,"twenty":-7.798032,"median":-7.107113,"eighty":-6.607942,"marketCap":171245139},{"date":"2023-12-22","current":-6.504358,"twenty":-7.362609,"median":-6.814731,"eighty":-6.515153,"marketCap":167721366},{"date":"2023-12-29","current":-7.296036,"twenty":-7.276244,"median":-6.747259,"eighty":-6.432387,"marketCap":188135585},{"date":"2024-01-05","current":-6.405398,"twenty":-7.70447,"median":-6.814731,"eighty":-6.412595,"marketCap":165169589},{"date":"2024-01-12","current":-7.251054,"twenty":-7.438178,"median":-6.882204,"eighty":-6.486365,"marketCap":186975686},{"date":"2024-01-19","current":-7.197076,"twenty":-7.362609,"median":-6.882204,"eighty":-6.515153,"marketCap":185583808},{"date":"2024-01-26","current":-6.837222,"twenty":-7.314029,"median":-6.823728,"eighty":-6.515153,"marketCap":176304617},{"date":"2024-02-02","current":-1.959536,"twenty":-7.276604,"median":-6.810233,"eighty":-6.462974,"marketCap":195790917},{"date":"2024-02-09","current":-1.845771,"twenty":-7.256092,"median":-6.76975,"eighty":-6.369412,"marketCap":184423909},{"date":"2024-02-16","current":-3.645108,"twenty":-7.218667,"median":-6.747259,"eighty":-3.756551,"marketCap":364208223},{"date":"2024-02-23","current":-6.848243,"twenty":-7.197076,"median":-6.729266,"eighty":-3.686899,"marketCap":684255939},{"date":"2024-03-01","current":-6.376994,"twenty":-7.189879,"median":-6.715257,"eighty":-3.782089,"marketCap":637170146},{"date":"2024-03-08","current":-6.913094,"twenty":-7.175485,"median":-6.740159,"eighty":-4.788696,"marketCap":690735636},{"date":"2024-03-15","current":-7.043277,"twenty":-7.155487,"median":-6.747259,"eighty":-6.236267,"marketCap":726936601},{"date":"2024-03-22","current":-7.516207,"twenty":-7.197076,"median":-6.792241,"eighty":-6.288445,"marketCap":775747691},{"date":"2024-03-28","current":-7.279742,"twenty":-7.276523,"median":-6.837222,"eighty":-6.349337,"marketCap":751342146},{"date":"2024-04-05","current":-6.925044,"twenty":-7.26113,"median":-6.876032,"eighty":-6.379076,"marketCap":714733828},{"date":"2024-04-12","current":-6.874373,"twenty":-7.240258,"median":-6.870151,"eighty":-6.391004,"marketCap":709504068},{"date":"2024-04-19","current":-5.983407,"twenty":-7.197076,"median":-6.842733,"eighty":-6.391004,"marketCap":617547460},{"date":"2024-04-26","current":-6.289752,"twenty":-7.193478,"median":-6.810233,"eighty":-6.342947,"marketCap":649165336},{"date":"2024-05-03","current":-6.546128,"twenty":-7.177285,"median":-6.792241,"eighty":-6.351434,"marketCap":675625879},{"date":"2024-05-10","current":-6.153019,"twenty":-7.167527,"median":-6.747259,"eighty":-6.342947,"marketCap":635053046},{"date":"2024-05-17","current":-6.063287,"twenty":-7.153064,"median":-6.743709,"eighty":-6.259918,"marketCap":625791856},{"date":"2024-05-24","current":-5.614629,"twenty":-7.135657,"median":-6.708499,"eighty":-6.098325,"marketCap":579485904},{"date":"2024-05-31","current":-4.486576,"twenty":-7.133587,"median":-6.688278,"eighty":-6.063287,"marketCap":463059513},{"date":"2024-06-07","current":-3.360659,"twenty":-7.131951,"median":-6.661794,"eighty":-5.648813,"marketCap":346853625},{"date":"2024-06-14","current":-4.27293,"twenty":-7.118439,"median":-6.651549,"eighty":-5.484732,"marketCap":441009060},{"date":"2024-06-21","current":-3.406965,"twenty":-7.110292,"median":-6.643683,"eighty":-5.017274,"marketCap":384687244},{"date":"2024-06-28","current":-3.508666,"twenty":-7.107113,"median":-6.634163,"eighty":-4.27293,"marketCap":396170446},{"date":"2024-07-05","current":-3.516489,"twenty":-7.107113,"median":-6.621073,"eighty":-3.815858,"marketCap":397053769},{"date":"2024-07-12","current":-3.5204,"twenty":-7.093203,"median":-6.587237,"eighty":-3.642484,"marketCap":397495431},{"date":"2024-07-15","current":-3.547781,"twenty":-7.089725,"median":-6.572786,"eighty":-3.63199,"marketCap":400587062},{"date":"2024-08-02","current":-3.446081,"twenty":-7.089604,"median":-6.558336,"eighty":-3.589657,"marketCap":389103860},{"date":"2024-08-09","current":-2.777205,"twenty":-7.088397,"median":-6.52142,"eighty":-3.527005,"marketCap":313579728},{"date":"2024-08-16","current":-2.307818,"twenty":-7.080829,"median":-6.504358,"eighty":-3.517271,"marketCap":260580338},{"date":"2024-08-23","current":-2.370403,"twenty":-7.05836,"median":-6.454878,"eighty":-3.458598,"marketCap":267646923},{"date":"2024-08-30","current":-2.573804,"twenty":-7.039722,"median":-6.405398,"eighty":-3.383305,"marketCap":290613326},{"date":"2024-09-06","current":-2.554246,"twenty":-7.025502,"median":-6.379484,"eighty":-3.290156,"marketCap":288405018},{"date":"2024-09-13","current":-2.400727,"twenty":-6.984161,"median":-6.343733,"eighty":-3.031456,"marketCap":293704957},{"date":"2024-09-20","current":-2.587735,"twenty":-6.954602,"median":-6.302571,"eighty":-2.628566,"marketCap":316583531},{"date":"2024-09-27","current":-1.987785,"twenty":-6.936182,"median":-6.238965,"eighty":-2.585538,"marketCap":243185673},{"date":"2024-10-04","current":-2.349201,"twenty":-6.925044,"median":-6.153019,"eighty":-2.573804,"marketCap":287401250},{"date":"2024-10-11","current":-2.479311,"twenty":-6.921741,"median":-6.080379,"eighty":-2.554246,"marketCap":303318858},{"date":"2024-10-18","current":-3.361165,"twenty":-6.921741,"median":-5.983407,"eighty":-2.554246,"marketCap":411204866},{"date":"2024-10-25","current":-3.216598,"twenty":-6.91854,"median":-5.659496,"eighty":-2.56605,"marketCap":393518635},{"date":"2024-10-31","current":-3.137087,"twenty":-6.914183,"median":-5.580446,"eighty":-2.572253,"marketCap":383791208},{"date":"2024-11-08","current":-3.035891,"twenty":-6.895579,"median":-5.443712,"eighty":-2.573804,"marketCap":371410846},{"date":"2024-11-15","current":-3.304095,"twenty":-6.884003,"median":-4.928824,"eighty":-2.580062,"marketCap":404222931},{"date":"2024-11-22","current":-3.195938,"twenty":-6.875939,"median":-4.2302,"eighty":-2.584756,"marketCap":390991104},{"date":"2024-11-29","current":-3.604285,"twenty":-6.87184,"median":-3.830846,"eighty":-2.585538,"marketCap":440948247},{"date":"2024-12-06","current":-3.600118,"twenty":-6.869976,"median":-3.719091,"eighty":-2.585538,"marketCap":440438480},{"date":"2024-12-13","current":-2.745924,"twenty":-6.85689,"median":-3.63199,"eighty":-2.586856,"marketCap":335936294},{"date":"2024-12-20","current":-2.483415,"twenty":-6.84163,"median":-3.604285,"eighty":-2.585538,"marketCap":303820988},{"date":"2024-12-27","current":-5.676196,"twenty":-6.836881,"median":-3.618138,"eighty":-2.585538,"marketCap":312996790},{"date":"2025-01-03","current":-6.526701,"twenty":-6.831143,"median":-3.666853,"eighty":-2.585977,"marketCap":359895332},{"date":"2025-01-10","current":-7.488141,"twenty":-6.86986,"median":-3.752745,"eighty":-2.587735,"marketCap":412911075},{"date":"2025-01-17","current":-6.480478,"twenty":-6.874373,"median":-4.2302,"eighty":-2.598578,"marketCap":357346498},{"date":"2025-01-24","current":-6.739327,"twenty":-6.870995,"median":-4.27293,"eighty":-2.60436,"marketCap":371619968},{"date":"2025-01-31","current":-6.563679,"twenty":-6.869918,"median":-5.380342,"eighty":-2.617897,"marketCap":361934399},{"date":"2025-02-07","current":-5.870333,"twenty":-6.868974,"median":-5.443712,"eighty":-2.624253,"marketCap":323701892},{"date":"2025-02-14","current":-5.777887,"twenty":-6.852345,"median":-5.580446,"eighty":-2.62701,"marketCap":318604225},{"date":"2025-02-21","current":-5.657707,"twenty":-6.84163,"median":-5.580446,"eighty":-2.628136,"marketCap":311977257},{"date":"2025-02-28","current":-5.398857,"twenty":-6.836711,"median":-5.546263,"eighty":-2.689586,"marketCap":297703787},{"date":"2025-03-07","current":-4.908892,"twenty":-6.833612,"median":-5.507012,"eighty":-2.739661,"marketCap":270686149},{"date":"2025-03-14","current":-3.949849,"twenty":-6.818849,"median":-5.443712,"eighty":-2.748264,"marketCap":272725216},{"date":"2025-03-21","current":-3.846555,"twenty":-6.800468,"median":-5.398857,"eighty":-2.766253,"marketCap":265593087},{"date":"2025-03-28","current":-3.506936,"twenty":-6.792928,"median":-5.371072,"eighty":-2.784959,"marketCap":242143410},{"date":"2025-04-04","current":-3.32236,"twenty":-6.792241,"median":-5.209343,"eighty":-2.829161,"marketCap":229399020},{"date":"2025-04-11","current":-2.953209,"twenty":-6.790707,"median":-4.908892,"eighty":-2.913999,"marketCap":203910240},{"date":"2025-04-17","current":-2.923677,"twenty":-6.772715,"median":-4.84418,"eighty":-2.93549,"marketCap":201871137},{"date":"2025-04-25","current":-2.953209,"twenty":-6.747259,"median":-4.251565,"eighty":-2.945826,"marketCap":203910240},{"date":"2025-05-02","current":-2.761251,"twenty":-6.747259,"median":-3.986833,"eighty":-2.932537,"marketCap":190656074},{"date":"2025-05-09","current":-2.502845,"twenty":-6.744419,"median":-3.927701,"eighty":-2.802203,"marketCap":172813928},{"date":"2025-05-16","current":-2.510228,"twenty":-6.739826,"median":-3.830846,"eighty":-2.747484,"marketCap":173323704},{"date":"2025-05-23","current":-3.167317,"twenty":-6.735303,"median":-3.794841,"eighty":-2.747484,"marketCap":218693732},{"date":"2025-05-30","current":-2.923677,"twenty":-6.725113,"median":-3.752745,"eighty":-2.752109,"marketCap":201871137},{"date":"2025-06-06","current":-2.672654,"twenty":-6.707049,"median":-3.661979,"eighty":-2.752109,"marketCap":184538767},{"date":"2025-06-13","current":-2.07932,"twenty":-6.698654,"median":-3.63591,"eighty":-2.725522,"marketCap":166091903},{"date":"2025-06-20","current":-2.104911,"twenty":-6.688278,"median":-3.604285,"eighty":-2.672654,"marketCap":168136111},{"date":"2025-06-27","current":-2.296849,"twenty":-6.667466,"median":-3.604285,"eighty":-2.62092,"marketCap":183467671},{"date":"2025-07-03","current":-2.431205,"twenty":-6.666527,"median":-3.583451,"eighty":-2.587296,"marketCap":194199763},{"date":"2025-07-11","current":-2.35443,"twenty":-6.659095,"median":-3.561833,"eighty":-2.580062,"marketCap":188067139},{"date":"2025-07-18","current":-2.35443,"twenty":-6.655298,"median":-3.539958,"eighty":-2.554246,"marketCap":188067139},{"date":"2025-07-25","current":-2.360828,"twenty":-6.649599,"median":-3.52355,"eighty":-2.534434,"marketCap":188578191},{"date":"2025-08-01","current":-2.424807,"twenty":-6.646743,"median":-3.5204,"eighty":-2.507148,"marketCap":193688711},{"date":"2025-08-08","current":-2.284053,"twenty":-6.64208,"median":-3.515844,"eighty":-2.48321,"marketCap":182445567},{"date":"2025-08-15","current":-2.309644,"twenty":-6.630054,"median":-3.506936,"eighty":-2.47065,"marketCap":184489775},{"date":"2025-08-22","current":-2.501582,"twenty":-6.623896,"median":-3.454767,"eighty":-2.461358,"marketCap":199821335},{"date":"2025-08-29","current":-3.039006,"twenty":-6.619926,"median":-3.440489,"eighty":-2.468312,"marketCap":242749704},{"date":"2025-09-05","current":-3.198953,"twenty":-6.619121,"median":-3.41834,"eighty":-2.469592,"marketCap":255526005},{"date":"2025-09-12","current":-3.269576,"twenty":-6.618902,"median":-3.418342,"eighty":-2.470386,"marketCap":309697518},{"date":"2025-09-19","current":-3.755157,"twenty":-6.607902,"median":-3.41834,"eighty":-2.472354,"marketCap":355692198},{"date":"2025-09-26","current":-3.512912,"twenty":-6.592605,"median":-3.443285,"eighty":-2.476912,"marketCap":332746511},{"date":"2025-10-03","current":-4.399246,"twenty":-6.573102,"median":-3.455255,"eighty":-2.481157,"marketCap":416701015},{"date":"2025-10-10","current":-4.804582,"twenty":-6.560473,"median":-3.482585,"eighty":-2.483004,"marketCap":455094844},{"date":"2025-10-17","current":-4.755942,"twenty":-6.551011,"median":-3.507507,"eighty":-2.493964,"marketCap":450487584},{"date":"2025-10-24","current":-4.250623,"twenty":-6.534472,"median":-3.514055,"eighty":-2.501348,"marketCap":402623278},{"date":"2025-10-31","current":-3.761518,"twenty":-6.52409,"median":-3.516489,"eighty":-2.50234,"marketCap":356294726},{"date":"2025-11-07","current":-3.253497,"twenty":-6.521235,"median":-3.517125,"eighty":-2.506072,"marketCap":308174461},{"date":"2025-11-14","current":-5.747343,"twenty":-6.512214,"median":-3.517762,"eighty":-2.509426,"marketCap":544394099},{"date":"2025-11-21","current":-4.499699,"twenty":-6.505293,"median":-3.5204,"eighty":-2.510823,"marketCap":426216021},{"date":"2025-11-28","current":-5.501905,"twenty":-6.50383,"median":-3.527462,"eighty":-2.515041,"marketCap":521145952},{"date":"2025-12-05","current":-5.803257,"twenty":-6.499968,"median":-3.539958,"eighty":-2.525832,"marketCap":549690322},{"date":"2025-12-12","current":-6.297452,"twenty":-6.489408,"median":-3.551776,"eighty":-2.533925,"marketCap":596500933},{"date":"2025-12-19","current":-5.767958,"twenty":-6.465686,"median":-3.579074,"eighty":-2.53967,"marketCap":546346707},{"date":"2025-12-26","current":-5.39637,"twenty":-6.439801,"median":-3.600118,"eighty":-2.547781,"marketCap":633005046},{"date":"2026-01-02","current":-5.156532,"twenty":-6.42501,"median":-3.604285,"eighty":-2.550334,"marketCap":604871488},{"date":"2026-01-09","current":-4.853878,"twenty":-6.414394,"median":-3.618138,"eighty":-2.554246,"marketCap":569369618},{"date":"2026-01-16","current":-5.26503,"twenty":-6.406521,"median":-3.645108,"eighty":-2.554246,"marketCap":617598574},{"date":"2026-01-23","current":-6.075913,"twenty":-6.405623,"median":-3.661979,"eighty":-2.563689,"marketCap":712716793},{"date":"2026-01-30","current":-5.864627,"twenty":-6.408096,"median":-3.687226,"eighty":-2.572253,"marketCap":687932468},{"date":"2026-02-06","current":-5.059454,"twenty":-6.405623,"median":-3.7399,"eighty":-2.573804,"marketCap":593484096},{"date":"2026-02-13","current":-5.676182,"twenty":-6.405398,"median":-3.755531,"eighty":-2.580062,"marketCap":665827530},{"date":"2026-02-20","current":-6.064492,"twenty":-6.394602,"median":-3.766923,"eighty":-2.583974,"marketCap":711377099},{"date":"2026-02-27","current":-5.727987,"twenty":-6.382652,"median":-3.78854,"eighty":-2.585538,"marketCap":671904343},{"date":"2026-03-06","current":-4.974154,"twenty":-6.379066,"median":-3.816552,"eighty":-2.585538,"marketCap":583478248},{"date":"2026-03-13","current":-3.994047,"twenty":-6.377711,"median":-3.830846,"eighty":-2.586856,"marketCap":489023101},{"date":"2026-03-20","current":-3.947541,"twenty":-6.357824,"median":-3.876947,"eighty":-2.594241,"marketCap":483328997},{"date":"2026-03-26","current":-3.868207,"twenty":-6.344748,"median":-3.882418,"eighty":-2.601469,"marketCap":473615524}],"updateTime":1774682388692},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ENGN\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2583065095","title":"enGene Holdings (ENGN) Valuation in Focus Following Promising Phase 2 Bladder Cancer Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2583065095","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583065095?lang=en_us&edition=fundamental","pubTime":"2025-11-14 19:21","pubTimestamp":1763119319,"startTime":"0","endTime":"0","summary":"enGene Holdings (ENGN) is drawing attention after announcing positive preliminary results from the pivotal cohort of its Phase 2 LEGEND trial. The data showed a high complete response rate and a favorable safety profile in challenging bladder cancer cases.\nSee our latest analysis for enGene Holdings.\nenGene Holdings’ impressive momentum really kicked in after its recent LEGEND trial data sent the stock soaring, highlighted by a 40% seven-day share price return and a staggering 129% gain over...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-engn/engene-holdings/news/engene-holdings-engn-valuation-in-focus-following-promising","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-engn/engene-holdings/news/engene-holdings-engn-valuation-in-focus-following-promising","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ENGN","BK4139","DCF"],"gpt_icon":0},{"id":"2583807595","title":"Exchange-Traded Funds Lower, Equity Futures Mixed Pre-Bell Thursday Amid Expected Economic Data Gaps","url":"https://stock-news.laohu8.com/highlight/detail?id=2583807595","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583807595?lang=en_us&edition=fundamental","pubTime":"2025-11-13 21:57","pubTimestamp":1763042229,"startTime":"0","endTime":"0","summary":"The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was down 0.2% and the actively traded Invesco QQQ Trust (QQQ) was 0.3% lower in Thursday's premarket activity as investors weighed th","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"70eb9cd7cf3b474dd15e72f3f7c2341c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ENGN","IGV","SOXX","IYJ","VHT.AU","IYE","DDS","IYK","RTH.AU","VHT","FAZ","XLF","XLI","XLY","EEM","CSCO","UNG","VDC","IYH","IVV","XLE","ARX","FAS","RTH",".IXIC","SPY.AU","PMR","USO","IBB","VIS","XRT","BWEN","XLK","IYW","SPY","ARX.AU","XLP",".DJI","XLV","EETH","XSD","TTE","EQR","IGM","BETH","BITO"],"gpt_icon":1},{"id":"2583523395","title":"EnGene Prices $130 Million Offering of Common Shares, Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2583523395","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583523395?lang=en_us&edition=fundamental","pubTime":"2025-11-13 16:37","pubTimestamp":1763023020,"startTime":"0","endTime":"0","summary":"EnGene  said Thursday it priced an underwritten public offering of 12.6 million shares at $8.50 per share and pre-funded warrants to purchase 2.7 million shares at $8.4999 per warrant for total expected gross proceeds of $130 million.The underwriters were granted a 30-day option to purchase up to 2.3 million additional shares.Closing of the offering is expected to occur on or about Friday, subject to customary closing conditions, the company said.Shares were 4.2% lower in premarket trade Thursday.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ENGN","BK4139"],"gpt_icon":0},{"id":"2583537820","title":"BRIEF-Engene Holdings Prices 12,558,823 Common Shares At $8.50 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2583537820","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583537820?lang=en_us&edition=fundamental","pubTime":"2025-11-13 13:28","pubTimestamp":1763011713,"startTime":"0","endTime":"0","summary":"BRIEF-Engene Holdings Prices 12,558,823 Common Shares At $8.50 Per ShareNov 13 (Reuters) - enGene Holdings Inc ENGN.O:ENGENE HOLDINGS INC  -  PRICING OF 12,558,823 COMMON SHARES AT A PUBLIC OFFERING P","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nFWN3WO1N8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENGN"],"gpt_icon":0},{"id":"2583553782","title":"enGene Holdings Inc  -  Pricing of 12,558,823 Common Shares at a Public Offering Price of $8.50 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2583553782","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583553782?lang=en_us&edition=fundamental","pubTime":"2025-11-13 13:27","pubTimestamp":1763011660,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nFWN3WO1N8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ENGN","BK4139"],"gpt_icon":0},{"id":"2583053104","title":"Could a Shift in enGene (ENGN) Trial Endpoints Reveal New Priorities in Its Clinical Strategy?","url":"https://stock-news.laohu8.com/highlight/detail?id=2583053104","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583053104?lang=en_us&edition=fundamental","pubTime":"2025-11-13 09:29","pubTimestamp":1762997381,"startTime":"0","endTime":"0","summary":"enGene Holdings recently reported additional preliminary efficacy data from its pivotal Phase 2 LEGEND trial for detalimogene voraplasmid in patients with high-risk, BCG-unresponsive non-muscle invasive bladder cancer, along with a protocol amendment changing the primary clinical endpoint after discussions with the FDA.\nThis update reveals that earlier patients in the study experienced a lower 12-month complete response rate compared to FDA-approved therapies, leading to significant...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-engn/engene-holdings/news/could-a-shift-in-engene-engn-trial-endpoints-reveal-new-prio","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-engn/engene-holdings/news/could-a-shift-in-engene-engn-trial-endpoints-reveal-new-prio","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","ENGN"],"gpt_icon":0},{"id":"2583581618","title":"EnGene Launches Offering of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2583581618","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583581618?lang=en_us&edition=fundamental","pubTime":"2025-11-13 06:53","pubTimestamp":1762988026,"startTime":"0","endTime":"0","summary":"EnGene (ENGN) said late Wednesday it launched an underwritten public offering of common shares.The company plans to offer underwriters a 30-day overallotment option to buy up to an additional 15% of the shares offered, according to a statement.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","ENGN"],"gpt_icon":0},{"id":"2583810586","title":"BRIEF-enGene Holdings Files For Offering Of Common Shares, Size Not Disclosed - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2583810586","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583810586?lang=en_us&edition=fundamental","pubTime":"2025-11-13 05:55","pubTimestamp":1762984530,"startTime":"0","endTime":"0","summary":"BRIEF-enGene Holdings Files For Offering Of Common Shares, Size Not Disclosed - SEC FilingNov 12  - enGene Holdings Inc ENGN.O:ENGENE HOLDINGS FILES FOR OFFERING OF COMMON SHARES, SIZE NOT DISCLOSED - SEC FILINGSource text: [ID:n0001193125-25-277833]Further company coverage: ENGN.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nFWN3WO1FS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENGN","BK4139"],"gpt_icon":0},{"id":"2583585007","title":"enGene Holdings Files for Offering of Common Shares, Size Not Disclosed - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2583585007","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583585007?lang=en_us&edition=fundamental","pubTime":"2025-11-13 05:53","pubTimestamp":1762984425,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nFWN3WO1FS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ENGN"],"gpt_icon":0},{"id":"2583458821","title":"enGene Announces Proposed Public Offering Of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2583458821","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583458821?lang=en_us&edition=fundamental","pubTime":"2025-11-13 05:12","pubTimestamp":1762981968,"startTime":"0","endTime":"0","summary":"Nov 12 (Reuters) - enGene Holdings Inc ::*ENGENE ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON SHARES  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 12-NOV-202521:01:00.337 GMT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nRSD2cmKQS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENGN"],"gpt_icon":0},{"id":"2582837746","title":"enGene Holdings Is Maintained at Market Outperform by Citizens","url":"https://stock-news.laohu8.com/highlight/detail?id=2582837746","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582837746?lang=en_us&edition=fundamental","pubTime":"2025-11-12 22:27","pubTimestamp":1762957620,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ENGN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 12, 2025 09:27 ET (14:27 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENGN"],"gpt_icon":0},{"id":"2582792533","title":"UBS Boosts Price Target on enGene Holdings to $10 From $4, Keeps Neutral Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2582792533","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582792533?lang=en_us&edition=fundamental","pubTime":"2025-11-12 21:00","pubTimestamp":1762952420,"startTime":"0","endTime":"0","summary":"enGene Holdings (ENGN) has an average rating of buy and mean price target of $23.70, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ban","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ENGN","BK4139"],"gpt_icon":0},{"id":"2582379355","title":"enGene Holdings Inc : UBS Raises Target Price to $10 From $4","url":"https://stock-news.laohu8.com/highlight/detail?id=2582379355","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582379355?lang=en_us&edition=fundamental","pubTime":"2025-11-12 20:54","pubTimestamp":1762952068,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nAZN4QQ2IB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ENGN","BK4139"],"gpt_icon":0},{"id":"2582396889","title":"Dow Gains More Than 300 Points; Energy Vault Holdings Shares Jump","url":"https://stock-news.laohu8.com/highlight/detail?id=2582396889","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582396889?lang=en_us&edition=fundamental","pubTime":"2025-11-12 01:17","pubTimestamp":1762881424,"startTime":"0","endTime":"0","summary":" ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/market-summary/25/11/48785671/dow-gains-more-than-300-points-energy-vault-holdings-shares-jump","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VOR","MNQmain","SRDX","SQQQ","BK4122","NVIW.SI",".IXIC","BK4082","ENGN","QLD","OM","TQQQ","PSQ","QID","BK4139","NQmain","REAL","BK4561","NRGV","USAW.SI","USJW.SI","TSYW.SI","PCOM","SLRX","BK4182","BK4094"],"gpt_icon":1},{"id":"2582398716","title":"enGene Holdings Up Over 61%, on Pace for Largest Percent Increase Since February 2024 -- Data Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2582398716","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582398716?lang=en_us&edition=fundamental","pubTime":"2025-11-11 23:51","pubTimestamp":1762876260,"startTime":"0","endTime":"0","summary":"enGene Holdings Inc.  is currently at $9.68, up $3.68 or 61.15%. --Would be highest close since Oct. 21, 2024, when it closed at $9.83. --On pace for largest percent increase since Feb. 14, 2024, when it rose 116.54%. --Up 45.64% year-to-date; on pace for best year on record . --Down 65.95% from its all-time closing high of $28.44 on Oct. 27, 2023. --Up 13.67% from 52 weeks ago , when it closed at $8.52. --Up 236.28% from its 52-week closing low of $2.88 on May 13, 2025. --Traded as high as $11.14; highest intraday level since May 31, 2024, when it hit $12.00","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENGN","BK4139"],"gpt_icon":0},{"id":"2582600153","title":"enGene Holdings Inc trading resumes","url":"https://stock-news.laohu8.com/highlight/detail?id=2582600153","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582600153?lang=en_us&edition=fundamental","pubTime":"2025-11-11 23:10","pubTimestamp":1762873827,"startTime":"0","endTime":"0","summary":"10:07 EST enGene (ENGN) Holdings Inc trading resumes Published first on TheFly – the ultimate source for real-time, market-moving breaking financia...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/engene-holdings-inc-trading-resumes-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/engene-holdings-inc-trading-resumes-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ENGN","BK4139"],"gpt_icon":0},{"id":"2582367497","title":"enGene reports detalimogene shows complete response rate of 62% at 6 months","url":"https://stock-news.laohu8.com/highlight/detail?id=2582367497","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582367497?lang=en_us&edition=fundamental","pubTime":"2025-11-11 22:36","pubTimestamp":1762871778,"startTime":"0","endTime":"0","summary":"enGene (ENGN) Holdings reported additional preliminary data from the pivotal cohort of its ongoing, Phase 2 LEGEND trial of detalimogene voraplasmi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/engene-reports-detalimogene-shows-complete-response-rate-of-62-at-6-months-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/engene-reports-detalimogene-shows-complete-response-rate-of-62-at-6-months-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ENGN"],"gpt_icon":0},{"id":"2582369605","title":"BRIEF-Detalimogene Demonstrates Improved Complete Response Rate Of 62% At 6 Months","url":"https://stock-news.laohu8.com/highlight/detail?id=2582369605","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582369605?lang=en_us&edition=fundamental","pubTime":"2025-11-11 20:53","pubTimestamp":1762865604,"startTime":"0","endTime":"0","summary":"BRIEF-Detalimogene Demonstrates Improved Complete Response Rate Of 62% At 6 MonthsNov 11 (Reuters) - enGene Holdings Inc ENGN.O:DETALIMOGENE DEMONSTRATES IMPROVED COMPLETE RESPONSE RATE OF 62% AT 6 MO","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251111:nTUA56H4S5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENGN"],"gpt_icon":0},{"id":"2582366472","title":"enGene Reports 62% Complete Response Rate at 6 Months in Phase 2 Bladder Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2582366472","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582366472?lang=en_us&edition=fundamental","pubTime":"2025-11-11 20:30","pubTimestamp":1762864234,"startTime":"0","endTime":"0","summary":"enGene Holdings Inc. has announced additional preliminary data from the pivotal cohort of its ongoing Phase 2 LEGEND trial evaluating detalimogene voraplasmid  in high-risk, Bacillus Calmette-Guérin -unresponsive non-muscle invasive bladder cancer  patients with carcinoma in situ , with or without concomitant papillary disease. The preliminary analysis included 62 patients at 3 months and 37 patients at 6 months. Detalimogene demonstrated a complete response rate of 62% at 6 months. The company reported that detalimogene's overall tolerability profile was favorable, with most treatment-related adverse events being Grade 1 or 2 in severity. enGene plans to submit a Biologics License Application  in the second half of 2026, pending further discussions with the FDA and the accumulation of sufficient 12-month complete response data. The company anticipates providing a data update on the LEGEND trial's pivotal cohort in the second half of 2026. Results from the trial were presented in the c","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251111:nNDL60QNJL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENGN","BK4139"],"gpt_icon":0},{"id":"2582662643","title":"Detalimogene Demonstrates Improved Complete Response Rate of 62% at 6 Months","url":"https://stock-news.laohu8.com/highlight/detail?id=2582662643","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582662643?lang=en_us&edition=fundamental","pubTime":"2025-11-11 20:30","pubTimestamp":1762864200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251111:nTUA56H4S5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ENGN","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":72,"code":"91000000","status":"200"}]}}